reports
- GlobalData Healthcare Department
Oncopeptides AB - Company Review
Oncopeptides AB - Company Review Summary Oncopeptides AB (Oncopeptides) is a pharmaceutical company which focuses on the development of oncology therapies to treat multiple myeloma. Its lead product Ygalo (melflufen), a peptidase potentiated therapy and a potent anti-angiogenetic compound. Ygalo is intended for the treatment of patients with late-stage relapsed and refractory multiple myeloma. Oncopeptides initiated an additional Phase II clinical trial of Ygalo in combination with dexamethaso...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.